bridgebio

BridgeBio Pharma is a biopharmaceutical company dedicated to developing transformative medicines for genetic diseases. The company operates with a decentralized, hub-and-spoke model designed for speed, precision, and scalability, allowing autonomous teams to focus on individual conditions while a central hub provides necessary clinical, regulatory, and commercial capabilities. This structure fosters a collaborative and innovative environment, enabling rapid translation of scientific advancements into life-changing therapies for patients with unmet needs.